(Press-News.org) The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.
They found that a lengthy treatment with 1 μM 5-azacitidine, without a significant effect on cell proliferation, sensitized cancer cells to the inhibitory effects of low-dose 6-mercaptopurine.
Importantly, treatment for several weeks with low doses of 6-mercaptopurine and/or 5-azacitidine did not render cancer cells resistant to chemotherapeutic drugs doxorubicin or paclitaxel.
In fact, the cells became more sensitive to chemotherapeutic drugs upon treatment with 6-mercaptopurine and/or 5-azacitidine.
The Oncotarget author's analyses of protein markers of epithelial-to-mesenchymal transition indicated that treatments with 6-mercaptopurine and/or 5-azacitidine do not significantly reverse this process in their model. Their results showed that safe drugs such as low-dose 6-mercaptopurine singly or combined with 5-azacitidine, which are suitable for use prior to disease relapse, have a potential of inhibiting highly resistant triple-negative breast cancer cells.
The Oncotarget author's analyses of protein markers of epithelial-to-mesenchymal transition indicated that treatments with 6-mercaptopurine and/or 5-azacitidine do not significantly reverse this process in their model.
Dr. Anthony Lucci and Dr. Balraj Singh both from The University of Texas MD Anderson Cancer Center said, "Breast cancer patients who have minimal residual disease (MRD) after surgery or systemic therapies are at a higher risk of relapse."
The model involves choosing cancer cell lines established from therapy-resistant breast cancers, such as inflammatory breast cancer, and subjecting them to prolonged glutamine deficiency to select progenitor-like cancer cells that are highly resistant and can metastasize to multiple organs in nude mice.
To explain this experimental strategy for therapeutic evaluation against resistant cancer cells, although their selection protocol for resistant cells is very robust, a majority of the progeny cells would gradually revert back to non-resistant cells in non-selective in vitro conditions.
Since a majority of relatively sensitive cells are preferentially eliminated first by most therapies, lengthy therapeutic evaluations in cell culture provide more useful information about the resistant subpopulation of cancer cells than rapid cell proliferation assays.
6-MP treatment affects cells via mis-incorporation of 6-thioguanine triphosphate into RNA and deoxy-6-thioguanine triphosphate into DNA along with other effects on nucleoside pools and cell signaling. The authors chose low-dose 6-MP for evaluation in our model of adaptable cancer cells because of 6-MP's ability to induce and maintain remission in inflammatory bowel disease and childhood acute lymphoblastic leukemia.
It has also been shown to stabilize quiescence in cancer cells and to sensitize resistant cancer cells to cell death with an apoptosis-inducing agent in a preclinical model of multiple myeloma.
The Lucci/Balraj Research Team concluded in their Oncotarget Research Output that finally, because immune checkpoint blockade therapy is likely to become common in both neoadjuvant and adjuvant settings in a heterogeneous cancer such as TNBC, the industry must consider any new therapy in this new context.
A common hurdle with the immune checkpoint therapy is severe autoimmune reaction toxicities.
When such therapies are given in the setting of metastasis, they may be combined with other therapies such as cytotoxic agents, which may also adversely affect immunity.
Although therapies like TNF antibodies are useful in managing the acute phase of IBD, 6-MP has been a mainstay for several decades for keeping the disease in remission.
Applying the lessons from IBD treatment to the setting cancer treatment, low-dose 6-MP followed by immune checkpoint blockade could be a good way of limiting severe autoimmune toxicities, thereby increasing the chances of success with these promising therapies.
Sign up for free Altmetric alerts about this article
DOI - https://doi.org/10.18632/oncotarget.27922
Full text - https://www.oncotarget.com/article/27922/text/
Correspondence to - Anthony Lucci - alucci@mdanderson.org and Balraj Singh - bsingh@mdanderson.org
Keywords -
esistant TNBC,
minimal residual disease,
intratumor heterogeneity,
breast cancer relapse,
metastasis prevention
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
No matter one's age, race, gender, socioeconomic status or political party, COVID-19 has impacted everyone at some level. That impact has been especially palpable for the approximately 1.3 million elderly Americans who reside in the country's 15,600 nursing homes.
Inside these facilities, the forced isolation caused by COVID-19 disrupted daily routines and left many of the residents with higher-then-normal levels of stress, anxiety and depression. Because many of these elderly individuals lack the resources or knowledge to use communications tools such as FaceTime or Zoom, their family and friends had no way to visit them except through a facility window.
What these family members couldn't see as they peered through their loved one's glass frame was the mental ...
CORVALLIS, Ore. - Researchers at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear.
The work centers around a large gene responsible for an inner-ear protein, otoferlin. Mutations in otoferlin are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing.
"For a long time otoferlin seemed to be a one-trick pony of a protein," said Colin Johnson, associate professor of biochemistry and biophysics in the OSU College of Science. "A lot of genes will find various things to do, but the ...
Rice farmers in Nepal are chronically falling short of their potential productivity. Poor rice yields are persistent across the Terai--a lowland region lying south of the outer foothills of the Himalayas that extends through southern Nepal into northern India--and existing decision support systems are failing to provide the precision required.
To date, farmers in the area have lacked the knowledge and support they need to properly plan nutrient applications for their crops. Current nutrient recommendation systems only provide "blanket" prescriptions that fail ...
VANCOUVER, Wash. - Employer COVID-19 safety measures influenced worker precautions even when they were not on the clock, according to a new study out of Washington State University.
The study found that workplace cultures that adopted COVID-19 prevention measures, such as daily health checks and encouraging sick workers to stay home, resulted in less "sickness presenteeism" or going places when feeling ill. The effect was found both inside and outside of work - meaning fewer employees with COVID-19 symptoms showed up to work and other public places like grocery stores, gyms and restaurants.
The same held true for attitudes toward the COVID-19 prevention measures recommended ...
While some international students come to Canada knowing whether they intend to stay or return home after completing their degrees, the majority decide after they have had a chance to live here for a few years, a new study has found.
"Nearly a quarter of our participants made the decision prior to arriving in Canada," said Elena Neiterman, a lecturer in the School of Public Health and Health Systems at the University of Waterloo. "However, the majority were not certain what their plans for the future were until they had a chance to live here and explore life in Canada."
The students identified several factors shaping their decision to stay or go, including family ties in Canada or abroad, ...
Researchers from Case Western Reserve University have identified a potential new approach to better controlling epileptic seizures.
Lin Mei, professor and chair of the Department of Neurosciences at the Case Western Reserve School of Medicine, who led the new study in mouse models, said the team found a new chemical reaction that could help control epileptic seizures.
Their findings were recently published in The Journal of Clinical Investigation.
Epilepsy is a neurological disorder in which abnormal brain activity causes seizures or periods of unusual behavior, sensations and sometimes loss of awareness.
A human brain contains about 86 billion nerve cells, also known as neurons. Eighty percent ...
Sophia Antipolis, 19 May 2021: Cities harbour a dangerous cocktail of environmental stressors which politicians must tackle to save lives and preserve health. That's the conclusion of a paper published today in European Heart Journal, a journal of the European Society of Cardiology (ESC).1
"By 2050, three in four people will live in cities, where up to 80% of energy is consumed and 70% of greenhouse gases are emitted," said study author Professor Thomas Münzel of the University Medical Centre Mainz, Germany. "There are limited actions that individuals can take to protect themselves from pollutants so politicians and policy makers need to take on this responsibility."
Cardiovascular diseases are the leading cause of mortality in Europe, accounting for 47% and ...
New research published in Anaesthesia (a journal of the Association of Anaesthetists) shows the huge pressure that anaesthesia and critical care staff in the UK have been under throughout the winter wave of COVID-19, as the number of newly admitted infected patients surged and most planned surgeries, including a substantial number of critical cancer operations, were cancelled.
"These findings have important implications for understanding what has happened during the COVID-19 pandemic, planning recovery and building a system that will better respond ...
A general practitioner, wife and mother has recounted her experience with COVID-19 which saw her stay in hospital 150 days and become one of the first patients to be treated with extracorporeal membrane oxygenation (ECMO), special equipment that completely takes over the function of the lungs and is a last resort option.
The self-written case report, which appears in the journal Anaesthesia Reports (a journal of the Association of Anaesthetists) is by Dr Anushua Gupta, who works as a general practitioner in Stockport, Greater Manchester, UK. It is thought to be the first patient-written account of ECMO to treat COVID-19 to appear in the medical literature.
Extracorporeal membrane oxygenation was introduced as ...
Simon Fraser University researchers are playing a key role in guiding conservation efforts to protect a declining butterfly population. The eastern monarch butterfly, an important pollinating species known for its distinct yellow-orange and black colour, is diminishing due to the loss of the milkweed plant--its primary food source.
Researchers analyzed current conservation strategies and recommended changes to how and where declining milkweed can be restored, based on assessments of climate and butterfly migration. Their study is published today in Frontiers in Environmental ...
